Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

Sinil Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	66,892	73,149	87,711	96,840	128,314	247,300
Market Cap Growth	-10.50%	-16.60%	-9.43%	-24.53%	-48.11%	229.18%
Enterprise Value	29,011	41,173	69,844	73,664	110,106	234,589
Last Close Price	5880.00	6430.00	7485.32	8067.47	10558.89	20160.16
PE Ratio	6.01	5.12	6.43	7.97	19.21	32.78
PS Ratio	0.83	0.82	0.98	1.21	2.08	4.03
PB Ratio	0.44	0.50	0.65	0.79	1.13	2.30
P/TBV Ratio	0.45	0.51	0.66	0.80	1.15	2.33
P/FCF Ratio	8.41	5.93	56.56	29.03	16.41	109.40
P/OCF Ratio	5.04	3.22	5.79	7.08	11.50	22.36
EV/Sales Ratio	0.36	0.46	0.78	0.92	1.78	3.82
EV/EBITDA Ratio	1.52	1.98	3.61	4.07	8.80	21.22
EV/EBIT Ratio	2.45	2.71	4.99	5.39	13.80	35.43
EV/FCF Ratio	3.65	3.34	45.04	22.08	14.08	103.77
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.02	0.02	0.03	0.01	0.02	0.04
Debt / FCF Ratio	0.04	0.04	0.35	0.04	0.04	0.17
Asset Turnover	0.49	0.56	0.60	0.59	0.49	0.51
Inventory Turnover	1.95	2.15	2.42	2.40	2.22	2.33
Quick Ratio	3.99	3.32	3.27	2.95	3.46	3.44
Current Ratio	5.63	4.71	4.86	4.22	4.86	5.08
Return on Equity (ROE)	7.67%	10.16%	10.57%	10.28%	6.05%	7.23%
Return on Assets (ROA)	4.49%	5.98%	5.92%	6.28%	3.93%	3.41%
Return on Invested Capital (ROIC)	8.94%	11.69%	12.04%	11.77%	6.88%	6.75%
Return on Capital Employed (ROCE)	7.60%	10.20%	10.10%	10.80%	6.80%	5.80%
Earnings Yield	16.91%	19.55%	15.55%	12.55%	5.21%	3.05%
FCF Yield	11.90%	16.85%	1.77%	3.45%	6.09%	0.91%
Payout Ratio	19.42%	13.74%	8.15%	8.89%	15.73%	14.92%
Buyback Yield / Dilution	0.02%	0.02%	-3.94%	1.05%	0.11%	2.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.